Noble Roman's, Inc.
NROM
$0.35
$0.0299.03%
| Weiss Ratings | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C | |||
| Rating Factors | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.80 | |||
| Price History | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.66% | |||
| 30-Day Total Return | -31.37% | |||
| 60-Day Total Return | 2.91% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 16.09% | |||
| 1-Year Total Return | 6.06% | |||
| 2-Year Total Return | 12.90% | |||
| 3-Year Total Return | -6.54% | |||
| 5-Year Total Return | -18.60% | |||
| 52-Week High % Change | -38.56% | |||
| 52-Week Low % Change | 33.75% | |||
| Price | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.52 | |||
| 52-Week Low Price | $0.24 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | May 02, 2024 | |||
| Valuation | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.13M | |||
| Enterprise Value | 18.49M | |||
| Price/Earnings (TTM) | 26.10 | |||
| Earnings Per Share (TTM) | 0.01 | |||
| Earnings Per Share Growth | 24.24% | |||
| Price/Earnings To Growth | 1.08 | |||
| Price/Sales (TTM) | 0.52 | |||
| Price/Book (Q) | 3.01 | |||
| Enterprise Value/Revenue (TTM) | 1.25 | |||
| Price | $0.35 | |||
| Enterprise Value/EBITDA (TTM) | 6.33 | |||
| Enterprise Value/EBIT | 8.04 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.15M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 317 634 3377 | |||
| Address | 6612 East 75th Street Indianapolis, IN 46250 | |||
| Website | www.nobleromans.com | |||
| Country | United States | |||
| Year Founded | 1972 | |||
| Profitability | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.55% | |||
| Profit Margin | 1.86% | |||
| Management Effectiveness | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.25% | |||
| Return on Equity | 9.83% | |||
| Income Statement | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 14.78M | |||
| Total Revenue (TTM) | 14.78M | |||
| Revenue Per Share | $0.61 | |||
| Gross Profit (TTM) | 4.38M | |||
| EBITDA (TTM) | 2.92M | |||
| EBIT (TTM) | 2.30M | |||
| Net Income (TTM) | 275.60K | |||
| Net Income Avl. to Common (TTM) | 275.60K | |||
| Total Revenue Growth (Q YOY) | 3.77% | |||
| Earnings Growth (Q YOY) | 25.11% | |||
| EPS Diluted (TTM) | 0.01 | |||
| EPS Diluted Growth (Q YOY) | 22.86% | |||
| Balance Sheet | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 551.50K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 2.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.37M | |||
| Current Ratio (Q) | 0.324 | |||
| Book Value Per Share (Q) | $0.11 | |||
| Total Assets (Q) | 16.85M | |||
| Total Current Liabilities (Q) | 9.18M | |||
| Total Debt (Q) | 11.91M | |||
| Total Liabilities (Q) | 14.48M | |||
| Total Common Equity (Q) | 2.37M | |||
| Cash Flow | NROM - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -23.60K | |||
| Cash from Financing (TTM) | -998.00K | |||
| Net Change in Cash (TTM) | -12.20K | |||
| Levered Free Cash Flow (TTM) | 1.80M | |||
| Cash from Operations (TTM) | 1.01M | |||
